CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 125 filers reported holding CYTOKINETICS INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $384,000 | +12.0% | 16,500 | 0.0% | 0.06% | +4.9% |
| Q4 2020 | $343,000 | -9.5% | 16,500 | -5.7% | 0.06% | -17.6% |
| Q3 2020 | $379,000 | -8.0% | 17,500 | 0.0% | 0.07% | -16.9% |
| Q2 2020 | $412,000 | +132.8% | 17,500 | +16.7% | 0.09% | +102.3% |
| Q1 2020 | $177,000 | -4.8% | 15,000 | -14.3% | 0.04% | +25.7% |
| Q4 2019 | $186,000 | -11.8% | 17,500 | -5.4% | 0.04% | -14.6% |
| Q3 2019 | $211,000 | +1.4% | 18,500 | 0.0% | 0.04% | +5.1% |
| Q2 2019 | $208,000 | +38.7% | 18,500 | 0.0% | 0.04% | +34.5% |
| Q1 2019 | $150,000 | +28.2% | 18,500 | 0.0% | 0.03% | +16.0% |
| Q4 2018 | $117,000 | -35.7% | 18,500 | 0.0% | 0.02% | -21.9% |
| Q3 2018 | $182,000 | +18.2% | 18,500 | 0.0% | 0.03% | +14.3% |
| Q2 2018 | $154,000 | +15.8% | 18,500 | 0.0% | 0.03% | +16.7% |
| Q1 2018 | $133,000 | -11.9% | 18,500 | 0.0% | 0.02% | -11.1% |
| Q4 2017 | $151,000 | – | 18,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,723,170 | $13,940,000 | 5.01% |
| RP Management, LLC | 875,656 | $7,084,000 | 3.54% |
| BVF INC/IL | 3,801,817 | $30,757,000 | 3.44% |
| DAFNA Capital Management LLC | 400,294 | $3,238,000 | 1.40% |
| Virtus ETF Advisers LLC | 33,758 | $273,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 67,352 | $545,000 | 0.44% |
| WASATCH ADVISORS LP | 3,188,487 | $25,795,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 1,459,706 | $11,809,000 | 0.26% |
| Campbell & CO Investment Adviser LLC | 43,844 | $355,000 | 0.18% |
| Fosun International Ltd | 239,792 | $1,981,000 | 0.13% |